A nosocomial outbreak due to novel CTX-M-2 producing strains of Citrobacter koseri in a hematological ward

Japanese Journal of Infectious Diseases

Volumn 59, Issue 1, 2006, Pages 69-71

  Muta, Tsuyoshi ^a   Tsuruta, Nobuko ^a   Seki, Yumiko ^a   Ota, Rika ^a   Suzuki, Satowa ^b   Shibata, Naohiro ^b   Kato, Koji ^a   Eto, Tetsuya ^a   Gondo, Hisashi ^a   Arakawa, Yoshichika ^b  

^a HAMANOMACHI HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTINEOPLASTIC AGENT; AZTREONAM; BACTERIAL DNA; BETA LACTAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFCAPENE PIVOXIL; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOTIAM; CEFPIROME; CEFPODOXIME PROXETIL; CEFTAZIDIME; CEPHALOSPORINASE; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID; FLOMOXEF; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MONOBACTAM DERIVATIVE; PIPERACILLIN; QUINOLONE; SULPERAZON;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY PRODUCTION; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BILIARY TRACT INFECTION; CANCER COMBINATION CHEMOTHERAPY; CATHETERIZATION; CELLULAR IMMUNITY; CITROBACTER KOSERI; DISEASE ASSOCIATION; DISEASE SEVERITY; DISINFECTION; EMPYEMA; ENTERITIS; ENTEROBACTERIACEAE; EPIDEMIC; FEBRILE NEUTROPENIA; GRAM NEGATIVE BACTERIUM; GRANULOCYTOPENIA; HAND WASHING; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; NONHUMAN; PERITONITIS; PHAGOCYTOSIS; PNEUMONIA; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SEPSIS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CITROBACTER KOSERI; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 33644522773     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Whitby, J. L. and Muir, G. G. (1961): Bacteriological studies of urinary tract infection. Br. J. Urol., 33, 130-134.
2. Madrazo, A., Geiger, J. and Lauter, C. B. (1975): Citrobacter diversus at grace hospital, Detroit, Michigan. Am. J. Med. Sci., 270, 497-501.
3. Lew, P. D., Baker, A. S., Kunz, L. J. and Moellering, R. C., Jr. (1984): Intra-abdominal Citrobacter infections: Association with biliary or upper gastrointestinal source. Surgery, 95, 398-403.
4. Kim, B. N., Woo, J. H., Ryu, J. and Kim, Y. S. (2003): Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia. Infection, 31, 202-207.
5. Underwood, S. and Avison, M. B. (2004): Citrobacter koseri and Citrobacter amalonaticus isolates carry highly divergent beta-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology. J. Antimicrob. Chemother., 53, 1076-1080.
6. El Harrif-Heraud, Z., Arpin, C., Benliman, S. and Quentin, C. (1997): Molecular epidemiology of a nosocomial outbreak due to SHV-4-producing strains of Citrobacter diversus. J. Clin. Microbiol., 35, 2561-2567.
7. Perilli, M., Mugnaioli, C., Luzzaro, F., Fiore, M., Stefani, S., Rossolini, G. M. and Amicosante, G. (2005): Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate. Antimicrob Agents Chemother., 49, 1564-1566.
8. Nagano, N., Nagano, Y., Cordevant, C., Shibata, N. and Arakawa, Y. (2004): Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J. Clin. Microbiol., 42, 3978-3984.
9. Nagano, N., Shibata, N., Saitou, Y., Nagano, Y. and Arakawa, Y. (2003): Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase. J. Clin. Microbiol., 41, 5530-5536.
10. Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M. S., Martinelli, G., Allione, B., D'Antonio, D., Buelli, M., Nosari, A. M., Cilloni, D., Zuffa, E., Cantaffa, R., Specchia, G., Amadori, S., Fabbiano, F., Deliliers, G.L., Lauria, F., Foa, R. and Del Favero, A. (2005): Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N. Engl. J. Med., 353, 977-987.
11. Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., Stuart, N., Rea, D., Bower, M., Fernando, I., Huddart, R., Gollins, S. and Stanley, A. (2005): Simple Investigation in Neutropenic Individuals of the Frequency of Infection after Chemotherapy +/ -Antibiotic in a Number of Tumours (SIGNIFICANT) Trial Group. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N. Engl. J. Med., 353, 988-998.
12. Cherif, H., Bjorkholm, M., Engervall, P., Johansson, P., Ljungman, P., Hast, R. and Kalin, M. (2004): A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Scand. J. Infect. Dis., 36, 593-600.
13. Raad, I. I., Escalante, C., Hachem, R. Y., Hanna, H. A., Husni, R., Afif, C., Boktour, M. R., Whimbey, E. E., Kontoyiannis, D., Jacobson, K., Kantarjian, H., Levett, L. M. and Rolston, K. V. (2003): Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer, 98, 1039-1047.